Molecular Targeted Immunotherapy Of Cancer: The Future Of Drug Innovation | 22620
Journal of Cancer Science & Therapy
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
This lecture will focus on a variety of topics related to tumour immunology & immunotherapy for clinical evaluation of
candidate therapeutics for treating several types of tumors, and will include discussion of: Hallmarks of Cancer: Applications
to cancer medicine; Targeted therapies in medical oncology: successes, failures and next steps; Inflammation in the genesis and
perpetuation of cancer; Linking stress system activity and immunity dysregulation to cancer development and progression:
inflammation in the genesis and perpetuation of cancer; Prognostic value and rationale of immunotherapy development;
Antibody therapy of cancer/Immunotherapy: combination and dosing schedule are key; Identification of therapeutic targets for
Immunomodulation and Cancer chemoprevention. In addition to these subjects, attendees of this lecture will be familiarized
with the need for rigorous and stringent testing of candidate immunotherapeutics, so that only the most promising therapies
are advanced to clinical trial evaluation of efficacy when treating patients in the era of Translational Oncology, from the bench
to the bedside.
Debora Dummer Meira is Pharmacyst specialized in Biochemistry, Master?s Pharmaceutical Sciences and PhD in Biosciences/Molecular Oncology at Brazilian
National Cancer Institute. She has studied tumor molecular biology and therapeutics for more than 15 years and has authored several peer-reviewed reports. She
is a member of the Scientific Brazilian Pharmaceutical Society in Oncology and President of Espirito Santo section. She also has experience in Pharmaceutical
Sciences, Targeted therapies in Oncology, Cancer Immunology & immunotherapy and Cancer Chemoprevention. Currently, is she is Professor and Researcher
at Federal University of Esp?rito Santo looking for agents to reverse, suppress and prevent carcinogenic progression and New Drugs in Cancer Immunotherapy.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals